Since 1998, Mr. Gifford has led The Foundry in all of its activities. These include the invention, identification and development of new technologies, the formation, financing, and staffing of over a dozen new companies, and ongoing support of these new ventures as a board member. Prior to The Foundry, Mr. Gifford was Vice President of Research and Development at Heartport, Inc. In 1992, Mr. Gifford co-founded and served as managing director of Bavaria Medizin Technologie, GmbH, establishing a German source for innovation and production of catheters for Interventional Cardiology. In 1990, Mr. Gifford served as President of Cardiovascular Therapeutic Technologies, Inc. which was acquired by Eli Lilly in 1991. From 1985-1990, Mr. Gifford worked at Devices for Vascular Intervention (DVI), where he served in various Engineering, Clinical Research and Marketing capacities. Before joining DVI, Hanson worked in engineering roles at Oximetrix, Inc. and General Dynamics. Mr. Gifford is a co-inventor on over 120 issued and 220 pending US patents. He earned his B.S. degree in mechanical engineering from Cornell University. Mr. Gifford serves as Chairman of the Board of Directors for ForSight Labs. He is a Director of Cabochon Aesthetics, Concentric Medical, Miramar Labs, Nexis Vision, and the latest Foundry and ForSight companies.